Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of pharmacogenetic-guided acenocoumarol dosing versus standard adjustment in venous thromboembolic disease
2009-016643-18Phase 4Active
- Sponsor
- FIBHULP
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of acenocoumarol in venous thromboembolism (VTE) (2 arms), sponsored by FIBHULP. Primary endpoint: Percentage of patients with INR within the therapeutic range on day 7. Started Nov 2009; status: active.
02
Drugs
acenocoumarol
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2009-016643-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016643-18.